In vivo activity of Nisin A and Nisin V against Listeria monocytogenes in mice

Nisin F-loaded brushite bone cement prevented the growth of Staphylococcus aureus in vivo

(2012) A.D. van Staden et al.   JOURNAL OF APPLIED MICROBIOLOGY

Bioengineered Nisin A Derivatives with Enhanced Activity against Both Gram Positive and Gram Negative Pathogens

(2012) Des Field et al.   PLoS One

Bioengineered nisin derivatives with enhanced activity in complex matrices

(2012) Susan Rouse et al.   Microbial Biotechnology

Efficacy of the New Lantibiotic NAI-107 in Experimental Infections Induced by Multidrug-Resistant Gram-Positive Pathogens

(2011) Daniela Jabés et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A 90-day oral toxicity study of nisin A, an anti-microbial peptide derived from Lactococcus lactis subsp. lactis, in F344 rats

(2010) Akihiro Hagiwara et al.   FOOD AND CHEMICAL TOXICOLOGY

The ability of nisin F to control Staphylococcus aureus infection in the peritoneal cavity, as studied in mice

(2010) A.M. Brand et al.   LETTERS IN APPLIED MICROBIOLOGY

The dawning of a ‘Golden era’ in lantibiotic bioengineering

(2010) Des Field et al.   MOLECULAR MICROBIOLOGY

Microbisporicin gene cluster reveals unusual features of lantibiotic biosynthesis in actinomycetes

(2010) L. C. Foulston et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Studies with bioengineered Nisin peptides highlight the broad-spectrum potency of Nisin V

(2010) Des Field et al.   Microbial Biotechnology

Bioengineering of a Nisin A-producing Lactococcus lactis to create isogenic strains producing the natural variants Nisin F, Q and Z

(2010) Clare Piper et al.   Microbial Biotechnology

Lantibiotics: Mode of Action, Biosynthesis and Bioengineering

(2009) G. Bierbaum et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

In vivo study on the effectiveness of pediocin PA-1 and Pediococcus acidilactici UL5 at inhibiting Listeria monocytogenes

(2009) Nassra Dabour et al.   INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY

Therapeutic potential of type A (I) lantibiotics, a group of cationic peptide antibiotics

(2008) Leif Smith et al.   CURRENT OPINION IN MICROBIOLOGY

Nisin F in the treatment of respiratory tract infections caused byStaphylococcus aureus

(2008) M. De Kwaadsteniet et al.   LETTERS IN APPLIED MICROBIOLOGY

The generation of nisin variants with enhanced activity against specific Gram-positive pathogens

(2008) Des Field et al.   MOLECULAR MICROBIOLOGY

Evaluation of developmental toxicity of microbicide Nisin in rats

(2007) Sadhana M. Gupta et al.   FOOD AND CHEMICAL TOXICOLOGY